- Home
- HCI vs NEO Comparison
HCI vs NEO Comparison
Compare HCI & NEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | HCI | NEO |
|---|---|---|
| Founded | 2006 | 2001 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Property-Casualty Insurers | Precision Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.3B | 2.1B |
| IPO Year | 2008 | 2008 |
Fundamental Metrics
Financial Performance| Metric | HCI | NEO |
|---|---|---|
| Price | $188.28 | $17.07 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 5 | 11 |
| Target Price | ★ $250.00 | $23.40 |
| AVG Volume (30 Days) | 142.2K | ★ 1.7M |
| Earning Date | 11-04-2026 | 10-28-2026 |
| Dividend Yield | ★ 0.86% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 17.48 | N/A |
| Revenue | ★ $900,946,000.00 | N/A |
| Revenue This Year | $9.33 | $11.12 |
| Revenue Next Year | $9.99 | $9.68 |
| P/E Ratio | $10.69 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $144.75 | $7.07 |
| 52 Week High | $208.80 | $20.15 |
Technical Indicators
Market Signals| Indicator | HCI | NEO |
|---|---|---|
| Relative Strength Index (RSI) | 41.94 | 48.87 |
| Support Level | $181.12 | $16.87 |
| Resistance Level | $196.13 | $17.19 |
| Average True Range (ATR) | 6.03 | 0.88 |
| MACD | -2.18 | 0.04 |
| Stochastic Oscillator | 18.65 | 48.44 |
Price Performance
Historical ComparisonAbout HCI HCI Group Inc.
HCI Group Inc is engaged in the property and casualty insurance business through two Florida domiciled insurance companies, Homeowners Choice Property & Casualty Insurance Company (HCPCI) and TypTap Insurance Company (TypTap). Both HCPCI and TypTap are authorized to underwrite various homeowners' property and casualty insurance products and allied lines business in the state of Florida and other states. The operating segments of the group are insurance operations, TypTap Group, reciprocal exchange operations, real estate operations, and corporate and other. It derives key revenue from the HCPCI Insurance operation segment.
About NEO NeoGenomics Inc.
NeoGenomics Inc provides oncology diagnostic testing and consultative services which include technical laboratory services and professional interpretation of laboratory test results by licensed physicians or molecular experts in pathology and oncology. The company operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. The company operates in a single segment and derives revenue from clients by providing clinical cancer testing, interpretation, and consultative services, molecular and NGS testing, comprehensive technical and professional services offerings, clinical trials and research, validation laboratory services, and oncology data solutions.